Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Capsule, Extended Release
Product Images NDC 0228-3064

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate (NDC 0228-3064). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

6df967f2-figure-01 (Image 1)

FDA Label Image

6df967f2-figure-10 (Image 10)

FDA Label Image

6df967f2-figure-11 (Image 11)

FDA Label Image

6df967f2-figure-12 (Image 12)

FDA Label Image

6df967f2-figure-13 (Image 13)

FDA Label Image

1 (Image 14)

This appears to be a medication guide for Dextroamphetamine and Amphetamine Sulfate extended-release capsules. The guide includes information about dosage, storage, and dispensing. The capsules are used to treat conditions such as Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy. It is important to note that this text is not entirely clear, and some characters are difficult to read, so some information may be missing or inaccurate.*

FDA Label Image

1 (Image 15)

This appears to be a medication guide for a prescription drug containing dextroamphetamine and amphetamine salts. The drug is an extended-release capsule and should be dispensed in a tight, light-resistant container. The guide provides dosage information and notes that the capsules contain a total amphetamine base equivalence of 6.3 milligrams. The medication guide number is Woc0228.3059.11 and the drug is manufactured by Teva.*

FDA Label Image

1 (Image 16)

This is a medication guide for Dextroamphetamine. It is an extended-release capsule containing various sulfates and monohydrates of amphetamines. It is available only through prescription and comes with 100 capsules per bottle. Each capsule has a specific dose of amphetamines and must be stored within a given temperature range. Pharmacists must provide the medication guide to each patient. The rest of the text contains manufacturing information and serialization coding area.*

FDA Label Image

1 (Image 17)

This text appears to be a description of a medication called Dextroamphetamine in the form of extended-release capsules. The medication consists of multiple compounds such as Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetartine Suifate, Amphetamine Sulfate. The medication is packaged in a bottle with a quantity of 100 capsules, with a dosage that can be found in the package literature. This medication requires a prescription and should be stored at 25°C (77°F) with some permitted fluctuation in temperature. The text also includes various codes/numbers which may be relevant to a pharmacist or healthcare provider.*

FDA Label Image

1 (Image 18)

This is a description of a medication called Dextroamphetamine, in the form of extended-release capsules, which contains a mix of four different types of amphetamine salts. The medication is only available with a prescription and comes in a bottle of 100 capsules. The label includes specific dosage information for adults and recommends dispensing the accompanying medication guide to patients. The medication should be stored in a tightly sealed, light-resistant container at a controlled room temperature. However, the text does not provide information on the specific use of this medication.*

FDA Label Image

1 (Image 19)

This is a description of a medication called Dextroamphetamine, which comes in an extended-release capsule form of mixed salts of a single entity. The medication is produced by Teva Parsippany and comes with 100 capsules per order. The text also provides instructions to store the capsules at 25°C (77°F) and explains that excursions are permitted to a certain limit.*

FDA Label Image

6df967f2-figure-02 (Image 2)

FDA Label Image

6df967f2-figure-03 (Image 3)

FDA Label Image

6df967f2-figure-04 (Image 4)

FDA Label Image

6df967f2-figure-05 (Image 5)

FDA Label Image

6df967f2-figure-06 (Image 6)

FDA Label Image

1 (Image 7)

This is a table showing the mean plasma concentrations of Dextro and Levoamphetamine over a period of 24 hours. The table contains information about immediate and extended-release medications of Dextroamphetamine and Levoamphetamine. The concentrations are measured in ng/mL.*

FDA Label Image

6df967f2-figure-08 (Image 8)

FDA Label Image

6df967f2-figure-09 (Image 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.